1. Home
  2. GEHC vs ROL Comparison

GEHC vs ROL Comparison

Compare GEHC & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • ROL
  • Stock Information
  • Founded
  • GEHC 1892
  • ROL 1948
  • Country
  • GEHC United States
  • ROL United States
  • Employees
  • GEHC N/A
  • ROL N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • ROL Diversified Commercial Services
  • Sector
  • GEHC Technology
  • ROL Finance
  • Exchange
  • GEHC Nasdaq
  • ROL Nasdaq
  • Market Cap
  • GEHC 33.1B
  • ROL 26.9B
  • IPO Year
  • GEHC N/A
  • ROL N/A
  • Fundamental
  • Price
  • GEHC $79.40
  • ROL $56.05
  • Analyst Decision
  • GEHC Buy
  • ROL Buy
  • Analyst Count
  • GEHC 9
  • ROL 9
  • Target Price
  • GEHC $84.89
  • ROL $61.44
  • AVG Volume (30 Days)
  • GEHC 2.9M
  • ROL 1.6M
  • Earning Date
  • GEHC 10-29-2025
  • ROL 10-29-2025
  • Dividend Yield
  • GEHC 0.18%
  • ROL 1.18%
  • EPS Growth
  • GEHC 41.40
  • ROL 6.56
  • EPS
  • GEHC 4.88
  • ROL 1.01
  • Revenue
  • GEHC $19,967,000,000.00
  • ROL $3,570,470,000.00
  • Revenue This Year
  • GEHC $6.02
  • ROL $12.34
  • Revenue Next Year
  • GEHC $4.59
  • ROL $8.88
  • P/E Ratio
  • GEHC $16.27
  • ROL $55.50
  • Revenue Growth
  • GEHC 2.31
  • ROL 10.38
  • 52 Week Low
  • GEHC $57.65
  • ROL $45.34
  • 52 Week High
  • GEHC $94.80
  • ROL $59.12
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 67.25
  • ROL 44.59
  • Support Level
  • GEHC $72.67
  • ROL $54.74
  • Resistance Level
  • GEHC $74.24
  • ROL $57.48
  • Average True Range (ATR)
  • GEHC 1.73
  • ROL 1.06
  • MACD
  • GEHC 0.59
  • ROL -0.05
  • Stochastic Oscillator
  • GEHC 96.40
  • ROL 39.46

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

Share on Social Networks: